Biotech entity
Every one of those 1 sits in a single category, pharma. Gavin Newsom is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Biocom California, all published on March 21, 2026.
Last mentioned: Mar 21, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Gavin Newsom is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Biocom California, all published on March 21, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 12 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Biocom California. Shared-story counts are live from our verified record — not editorial picks.
California is facing a critical exodus of life sciences and biotech firms as high taxes and aggressive regulatory frameworks clash with the state's pro-innovation rhetoric. Industry leaders warn that the rising cost of doing business is forcing established players and startups alike to relocate to more business-friendly states.
Biocom California is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
